Triple HIV-1 infection.
نویسندگان
چکیده
2557 tives on racial and ethnic differences in health in late life. Washington, D.C.: National Academies Press, 2004:643-74. 3. HIV/AIDS surveillance report. Vol. 8. No. 2. Atlanta: Centers for Disease Control and Prevention, 1996:28. 4. HIV/AIDS surveillance report. Vol. 15. Atlanta: Centers for Disease Control and Prevention, 2003:12. 5. Jaffe H. Whatever happened to the U.S. AIDS epidemic? Science 2004;305:1243-4.
منابع مشابه
Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.
BACKGROUND Few studies exist on hospital-based seroprevalence of triple positivity of HIV/HBV/HCV in Nigeria. OBJECTIVES The study aimed at determining the triple positivity of HIV, HBsAg and HCV among HIV-infected individuals in Abeokuta, Nigeria and defining the influence of these triple infections on CD4+ counts of HIV-infected individuals as antiretroviral therapy improves in Nigeria. M...
متن کاملSimilar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infection.
We compared the time to viral suppression between a cohort of 70 primary HIV infected (PHI-) patients treated with triple-class therapy and a cohort of 80 naive chronic HIV infected (CHI-) patients with comparable treatment and plasma viral load (≥100.000 copies/ml) at start of cART. The time to viral suppression after initiation of triple-class therapy was comparable for PHI and CHI, suggestin...
متن کاملNo advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia.
BACKGROUND We assessed whether quadruple or triple-class therapy for the initial treatment of HIV-1 infection provides a virological benefit over standard triple therapy in patients with very high plasma viraemia. The assessment was made based on a national observational HIV cohort in the Netherlands. METHODS Inclusion criteria were age ≥18 years, treatment-naive, plasma viral load (pVL) ≥500...
متن کاملTime to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection.
To estimate the change in AIDS incubation time during three periods characterized by different availability of antiretroviral treatments, data from the French Hospital Database on HIV of 4702 HIV-1-positive subjects with a documented date of infection were analyzed. Times from seroconversion to AIDS were compared in three periods: period 1 from January 1992 to June 1995 (monotherapy); period 2 ...
متن کاملEffects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection.
A combination of zidovudine, didanosine, and lamivudine was used to treat 10 patients with primary human immunodeficiency virus type 1 (HIV-1) infection 5-28 days after the onset of symptoms. When therapy began, the mean plasma HIV-1 RNA level was 5.31 +/- 0.33 log10 copies/mL and the mean CD4 T cell count was 630 +/- 112 x 10(6)/L. The plasma HIV-1 RNA level decreased rapidly, and levels dropp...
متن کاملHepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.
The incidence rate of hepatic decompensation was higher in patients with human immunodeficiency virus (HIV)/hepatitis B virus (HBV)/hepatitis C virus (HCV) triple infection than in those with HIV/HCV coinfection (24.1 vs 10.8 events per 1000 person-years; hazard ratio [HR], 1.89; 95% confidence interval [CI], 1.12-3.18). Compared with HIV/HCV-infected patients, the rate of decompensation was in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The New England journal of medicine
دوره 352 24 شماره
صفحات -
تاریخ انتشار 2005